Brief: Crossject raises 5 mln euros in capital increase
April 5 (Reuters) - Crossject SA ALCJ.PA :
* Successful capital increase
* Subscription rate of 137 pct, amount increased to
approximately 4.98 million euros ($5.31 million) after the
exercise of extension clause
Source text for Eikon: ID:nGNE1xMmVJ
Further company coverage: ALCJ.PA
($1 = 0.9384 euros)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Crossject SA
See all newsBrief: Crossject Says Expects To File For EUA Early Next Year For Epilepsy Rescue Therapy Zepizure
Brief: Crossject Signs A Geographic Extension Of Zepizure Commercialization Agreement In Europe
Brief: Crossject FY Operating Income Up At EUR 12.82 Mln
Brief: Crossject Announces Contract Of Up To $155 Mln With BARDA
Brief: Crossject Engages Syneos Health For U.S. Commercial Launch Of Zepizure